Search by Medical Condition
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for Osteopetrosis
- Study of Gene Modified Donor T-cells Following TCR Alpha Beta Positive Depleted Stem Cell Transplant
- ACTIMMUNE in Intermediate Osteopetrosis
- Use of ACTIMMUNE in Patients With ADO2
- MT2013-31: Allo HCT for Metabolic Disorders and Severe Osteopetrosis
- Safety Study of Gene Modified Donor T-cells Following TCR Alpha Beta Depleted Stem Cell Transplant
- Hematopoietic Stem Cell Transplantation for Malignant Infantile Osteopetrosis
- Risk-Adapted Allogeneic Stem Cell Transplantation For Mixed Donor Chimerism In Patients With Non-Malignant Diseases
- Allogeneic Transplantation For Severe Osteopetrosis
- Reduced Intensity AlloTransplant For Osteopetrosis
- rhPTH Therapy for Low Turnover Bone Fragility
- Stem Cell Transplantation for Children Affected With Osteopetrosis
- Post Marketing Surveillance Study of Actimmune in Patients With Severe, Malignant Osteopetrosis
- Phase III Randomized Study of Interferon Gamma in Children With Severe, Congenital Osteopetrosis